Identification and Construction of a Predictive Immune-Related lncRNA Signature Model for Melanoma

References

• Slominski A, Wortsman J, Carlson AJ, Matsuoka LY, Balch CM, Mihm MC. Malignant melanoma. Arch Pathol Lab Med. 2001;125(10):1295–1306. doi:10.5858/2001-125-1295-MM
   PubMed Web of Science ®Google Scholar
• Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol. 2014;9:239–271. doi:10.1146/annurev-pathol-012513-104658
   PubMed Web of Science ®Google Scholar
• Pastor-Tomás N, Martínez-Franco A, Bañuls J, et al. Risk factors for the development of a second melanoma in patients with cutaneous melanoma. J Eur Acad Dermatol Venereol. 2020;34(10):2295–2302. doi:10.1111/jdv.16341
   PubMed Web of Science ®Google Scholar
• Raimondi S, Suppa M, Gandini S. Melanoma epidemiology and sun exposure. Acta Derm Venereol. 2020;100(11):adv00136. doi:10.2340/00015555-3491
   PubMed Web of Science ®Google Scholar
• Xie J, Li H, Chen L, et al. A novel pyroptosis-related lncRNA signature for predicting the prognosis of skin cutaneous melanoma. Int J Gen Med. 2021;14:6517–6527. doi:10.2147/IJGM.S335396
   PubMed Web of Science ®Google Scholar
• Müller C, Wendt J, Rauscher S, et al. Risk factors of subsequent primary melanomas in Austria. JAMA Dermatol. 2019;155(2):188–195. doi:10.1001/jamadermatol.2018.4645
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20(11):1366–1379. doi:10.1080/15384047.2019.1640032
   PubMed Web of Science ®Google Scholar
• Kandolf Sekulovic L, Guo J, Agarwala S, et al. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries. Eur J Cancer. 2018;104:201–209. doi:10.1016/j.ejca.2018.09.013
   PubMed Web of Science ®Google Scholar
• Margolin K. Introduction to the role of the immune system in melanoma. Hematol Oncol Clin North Am. 2014;28(3):537–558. doi:10.1016/j.hoc.2014.02.005
   PubMed Web of Science ®Google Scholar
• Attrill GH, Ferguson PM, Palendira U, Long GV, Wilmott JS, Scolyer RA. The tumour immune landscape and its implications in cutaneous melanoma. Pigment Cell Melanoma Res. 2021;34(3):529–549. doi:10.1111/pcmr.12926
   PubMed Web of Science ®Google Scholar
• Tang L, Zhang W, Su B, Yu B. Long noncoding RNA HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma. Biomed Res Int. 2013;2013:251098. doi:10.1155/2013/251098
   PubMed Web of Science ®Google Scholar
• Cantile M, Scognamiglio G, Marra L, et al. HOTAIR role in melanoma progression and its identification in the blood of patients with advanced disease. J Cell Physiol. 2017;232(12):3422–3432. doi:10.1002/jcp.25789
   PubMed Web of Science ®Google Scholar
• Tian Y, Zhang X, Hao Y, Fang Z, He Y. Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma. Melanoma Res. 2014;24(4):335–341. doi:10.1097/CMR.0000000000000080
   PubMed Web of Science ®Google Scholar
• Li R, Zhang L, Jia L, et al. Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation. PLoS One. 2014;9(6):e100893. doi:10.1371/journal.pone.0100893
   PubMed Web of Science ®Google Scholar
• Curran MA, Montalvo W, Yagita H, Allison JP. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A. 2010;107(9):4275–4280. doi:10.1073/pnas.0915174107
   PubMed Web of Science ®Google Scholar
• Gao J, Zeng K, Liu Y, Gao L, Liu L. LncRNA SNHG5 promotes growth and invasion in melanoma by regulating the miR-26a-5p/TRPC3 pathway. Onco Targets Ther. 2019;12:169–179. doi:10.2147/OTT.S184078
   PubMed Web of Science ®Google Scholar
• Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73(13):2491–2509. doi:10.1007/s00018-016-2174-5
   PubMed Web of Science ®Google Scholar
• Qiu Y, Li H, Xie J, Qiao X, Wu J. Identification of ABCC5 among ATP-binding cassette transporter family as a new biomarker for hepatocellular carcinoma based on bioinformatics analysis. Int J Gen Med. 2021;14:7235–7246. doi:10.2147/IJGM.S333904
   PubMed Web of Science ®Google Scholar
• Wang H, Yang L, Wang D, Zhang Q, Zhang L. Pro-tumor activities of macrophages in the progression of melanoma. Hum Vaccin Immunother. 2017;13(7):1556–1562. doi:10.1080/21645515.2017.1312043
   PubMed Web of Science ®Google Scholar
• Choo YW, Kang M, Kim HY, et al. M1 macrophage-derived nanovesicles potentiate the anticancer efficacy of immune checkpoint inhibitors. ACS Nano. 2018;12(9):8977–8993. doi:10.1021/acsnano.8b02446
   PubMed Web of Science ®Google Scholar
• Wang Q, Yang W, Peng W, Qian X, Zhang M, Wang T. Integrative analysis of DNA methylation data and transcriptome data identified a DNA methylation-dysregulated four-LncRNA signature for predicting prognosis in head and neck squamous cell carcinoma. Front Cell Dev Biol. 2021;9:666349. doi:10.3389/fcell.2021.666349
   PubMed Web of Science ®Google Scholar
• Liu G, Zheng J, Zhuang L, et al. A prognostic 5-lncRNA expression signature for head and neck squamous cell carcinoma. Sci Rep. 2018;8(1):15250. doi:10.1038/s41598-018-33642-1
   PubMed Web of Science ®Google Scholar
• Bida O, Gidoni M, Ideses D, Efroni S, Ginsberg D. A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget. 2015;6(29):27880–27890. doi:10.18632/oncotarget.4944
   PubMedGoogle Scholar
• Jacquelot N, Duong CPM, Belz GT, Zitvogel L. Targeting chemokines and chemokine receptors in melanoma and other cancers. Front Immunol. 2018;9:2480. doi:10.3389/fimmu.2018.02480
   PubMed Web of Science ®Google Scholar
• Weber R, Riester Z, Hüser L, et al. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. J Immunother Cancer. 2020;8(2):e000949. doi:10.1136/jitc-2020-000949
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Lied A, Kulkarni V, et al. CCR5AS lncRNA variation differentially regulates CCR5, influencing HIV disease outcome. Nat Immunol. 2019;20(7):824–834. doi:10.1038/s41590-019-0406-1
   PubMed Web of Science ®Google Scholar
• Zou S. Variation of CCR5AS lncRNA enhances HIV-1 infection through regulation of CCR5 expression. Viral Immunol. 2020;33(8):536–538. doi:10.1089/vim.2020.0034
   PubMed Web of Science ®Google Scholar
• Xiao B, Liu L, Li A, et al. Identification and validation of immune-related lncRNA prognostic signatures for melanoma. Immun Inflamm Dis. 2021;9(3):1044–1054. doi:10.1002/iid3.468
   PubMed Web of Science ®Google Scholar
• Wan J, Guo C, Fang H, Xu Z, Hu Y, Luo Y. Autophagy-related long non-coding RNA is a prognostic indicator for bladder cancer. Front Oncol. 2021;11:647236. doi:10.3389/fonc.2021.647236
   PubMed Web of Science ®Google Scholar
• Hou J, Yao C. Potential prognostic biomarkers of lung adenocarcinoma based on bioinformatic analysis. Biomed Res Int. 2021;2021:8859996. doi:10.1155/2021/8859996
   PubMed Web of Science ®Google Scholar
• Chen L, Ren Z, Cai Y. Construction and analysis of survival-associated competing endogenous RNA network in lung adenocarcinoma. Biomed Res Int. 2021;2021:4093426. doi:10.1155/2021/4093426
   PubMed Web of Science ®Google Scholar
• Zimta AA, Tomuleasa C, Sahnoune I, Calin GA, Berindan-Neagoe I. Long non-coding RNAs in myeloid malignancies. Front Oncol. 2019;9:1048. doi:10.3389/fonc.2019.01048
   PubMed Web of Science ®Google Scholar
• Affinito O, Pane K, Smaldone G, et al. lncRNAs-mRNAs co-expression network underlying childhood B-cell acute lymphoblastic leukaemia: a pilot study. Cancers. 2020;12(9):2489. doi:10.3390/cancers12092489
   PubMed Web of Science ®Google Scholar
• Shen FF, Pan Y, Yang HJ, et al. Decreased expression of SPINT1-AS1 and SPINT1 mRNA might be independent unfavorable prognostic indicators in esophageal squamous cell carcinoma. Onco Targets Ther. 2019;12:4755–4763. doi:10.2147/OTT.S206448
   PubMed Web of Science ®Google Scholar
• Zhou T, Lin K, Nie J, et al. LncRNA SPINT1-AS1 promotes breast cancer proliferation and metastasis by sponging let-7 a/b/i-5p. Pathol Res Pract. 2021;217:153268. doi:10.1016/j.prp.2020.153268
   PubMed Web of Science ®Google Scholar
• Qi-Dong X, Yang X, Lu JL, et al. Development and validation of a nine-redox-related long noncoding RNA signature in renal clear cell carcinoma. Oxid Med Cell Longev. 2020;2020:6634247. doi:10.1155/2020/6634247
   PubMed Web of Science ®Google Scholar